Here's one old-world medicine sell and one precision medicine buy for your 2021 portfolio … before our nation's $3.6 trillion health care disruption.

1 Sell Before $3.6 Trillion Precision Medicine Disruption By Nick Tate Dear Bold Investor, Most prescriptions don’t work. It may be hard to imagine today, but Big Pharma companies — and its drugs — are the old-world of medicine. The reason: Big Pharma spends billions developing one-size-fits-all drugs prescribed for tens of millions of Americans. They’re all the same. Does that make any sense at all? You’re not the same as your next-door neighbor. You’re not built the same, you’re not the same height, weight … and your genetic makeup isn’t exactly the same, either. But Big Pharma doesn’t take that into consideration when it pushes out all of those expensive medicines that might work for some. There’s a better way … a new revolution in your health care … an America 2.0 way called precision medicine. So today, I’m going to tell you about one Big Pharma Blacklist company to clear out of your portfolio. And one precision medicine buy to give you exposure to this new disruptive market … one that will replace the $3.6 trillion American health care industry. Former Wall Street Insider Exposes a 100% Legal Way to Capture Life-Changing Gains! “The reason you’ll never hear about this secret is because Wall Street doesn’t want you to know. This is how insiders make their money. And if you knew, you’d be invading their turf.” Get the full story here. You Can Save $11,172 Every Year Millions of people take some kind of prescription every day. One that may or may not work for them. In fact, a new report found that 75% of all cancer patients don’t benefit from the conventional one-size-fits-all drugs they take. For Alzheimer’s patients, that figure is 70%, for arthritis it’s 50%, diabetes 43%, asthma 40% and depression 38%. (Click here to view larger image.) Excuse my language, but that’s just dumb! With the innovation and biotech we have today, we need medications that WILL work. Medications that are tailored to our unique genetic makeup and biological factors. Now for the good news: Precision medicine is the answer to this old-world problem. As I mentioned, it’ll create a huge disruption in American health care to the tune of $3.6 trillion — that includes medications, tests and treatments. A system that accounts for 17.7% of our gross domestic product and soaks up an average of $11,172 from nearly every American each year. Precision medicine gives doctors the ability to conduct genetic tests on their patients to match treatments to each individual. There are already around 75,000 genetic tests on the market. How big is the trend and the opportunity for investors? In a word: Phenomenal! According to the new Personalized Medicine Coalition report, the number of new therapies on the market has skyrocketed over the past 12 years — from just five precision medicine drugs in 2008 to 286 so far this year. That’s a 5,620% increase! (Click here to view larger image.) And that’s only the beginning. We believe it will completely dominate the health care marketplace in the next three to five years. And that tells me these new therapies that are replacing old-world Big Pharma dinosaurs give us an astonishing investment opportunity. Replace the Old for the New In Your 2021 Portfolio Precision medicine is a key mega trend for the Fourth Industrial Revolution. It’s on track to become a $216.75 billion global industry by 2028 — a 175% increase since 2018. And we want you in this trend to get the most gains from it before it rockets higher. So, here are two steps to get your precision medicine portfolio in top shape for 2021: No. 1: Sell the Big Pharma stock on Paul’s America 2.0 Blacklist. One old-world pharmaceutical company to get rid of is: Bristol-Myers Squibb Company (NYSE: BMY). The Blacklist is Paul’s report on 100 stocks that he believes will go bankrupt as the new Fourth Industrial Revolution takes off. You can see Paul’s full Blacklist and what he DOES recommend for the biggest profits in America 2.0 by clicking here. No. 2: Buy a precision medicine gem that will give you exposure to this new revolution. I recommend the SPDR S&P Biotech ETF (NYSE: XBI). This exchange-traded fund (ETF) lets you profit from more than 120 U.S. biotech stocks at the center of the precision medicine trend. The ETF has been a huge success story for investors this year, rising nearly 121% since March! There are more precision medicine profits ahead. Stay tuned for our full America 2.0 coverage of this mega trend in 2021! To your health and wealth, Nick Tate Senior Editorial Manager, Banyan Hill Publishing Editor’s Note: Ready to invest for 2021? Here’s Paul’s investing blueprint. It has all his top strategies — GoingUpness, Rules of the Game, Strong Hands — and how he’s applied them over the years to find stock market winners. Find out how to get your copy today. Bigger Than Tesla? 2 EV Buys for 10X Growth! 26X Bigger Than the Coronavirus Stimulus Bill 4 Stocks for Space: Look UP for 2021 Gains Privacy Policy Bold Profits Daily, P.O. Box 8378, Delray Beach, FL 33482. To ensure that you receive future issues of Bold Profits Daily, please add info@mb.banyanhill.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. The mailbox associated with this email address is not monitored, so please do not reply. Your feedback is very important to us so if you would like to contact us with a question or comment, please click here: http://banyanhill.com/contact-us Legal Notice: This work is based on what we've learned as financial journalists. It may contain errors and you should not base investment decisions solely on what you read here. It's your money and your responsibility. Nothing herein should be considered personalized investment advice. Although our employees may answer general customer service questions, they are not licensed to address your particular investment situation. Our track record is based on hypothetical results and may not reflect the same results as actual trades. Likewise, past performance is no guarantee of future returns. Certain investments carry large potential rewards but also large potential risk. Don't trade in these markets with money you can't afford to lose. Banyan Hill Publishing expressly forbids its writers from having a financial interest in their own securities or commodities recommendations to readers. Such recommendations may be traded, however, by other editors, Banyan Hill Publishing, its affiliated entities, employees, and agents, but only after waiting 24 hours after an internet broadcast or 72 hours after a publication only circulated through the mail. (c) 2020 Banyan Hill Publishing. All Rights Reserved. Protected by copyright laws of the United States and treaties. This Newsletter may only be used pursuant to the subscription agreement. Any reproduction, copying, or redistribution, (electronic or otherwise) in whole or in part, is strictly prohibited without the express written permission of Banyan Hill Publishing. P.O. Box 8378, Delray Beach, FL 33482. (TEL: 866-584-4096) Remove your email from this list: click here to unsubscribe.